BioCentury
ARTICLE | Financial News

Genexine completes convertible debt financing

July 25, 2016 7:00 AM UTC

Genexine Inc. (KOSDAQ:095700), Seoul, South Korea Business: Endocrine/Metabolic, Cancer, Hematology Date completed: 2016-06-29 Type: Convertible debt financing Raised: W20 billion ($18 million) Invest...